BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29470146)

  • 21. [The cannabinoid system and pain: towards new drugs?].
    Beltramo M
    J Soc Biol; 2009; 203(1):99-106. PubMed ID: 19358815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1.
    Fresno N; Pérez-Fernández R; Goicoechea C; Alkorta I; Fernández-Carvajal A; de la Torre-Martínez R; Quirce S; Ferrer-Montiel A; Martín MI; Goya P; Elguero J
    PLoS One; 2014; 9(12):e113841. PubMed ID: 25438056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential innovative targets in the treatment of pain: Combined µ and NOP receptor agonists.
    Leo RJ
    J Opioid Manag; 2021; 17(4):277-283. PubMed ID: 34533821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug management of visceral pain: concepts from basic research.
    Davis MP
    Pain Res Treat; 2012; 2012():265605. PubMed ID: 22619712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational pain research: evaluating analgesic effect in experimental visceral pain models.
    Olesen AE; Andresen T; Christrup LL; Upton RN
    World J Gastroenterol; 2009 Jan; 15(2):177-81. PubMed ID: 19132767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors.
    Lee CW; Ho IK
    Mol Pain; 2013 Sep; 9():45. PubMed ID: 24010861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid receptors: toward separation of analgesic from undesirable effects.
    Law PY; Reggio PH; Loh HH
    Trends Biochem Sci; 2013 Jun; 38(6):275-82. PubMed ID: 23598157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights From Molecular Dynamics Simulations of a Number of G-Protein Coupled Receptor Targets for the Treatment of Pain and Opioid Use Disorders.
    Ribeiro JML; Filizola M
    Front Mol Neurosci; 2019; 12():207. PubMed ID: 31507375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRPC5 and the path towards analgesic drug development.
    Denk F
    Trends Neurosci; 2021 Sep; 44(9):687-688. PubMed ID: 34274149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutic approaches to the treatment of chronic abdominal visceral pain.
    Patrizi F; Freedman SD; Pascual-Leone A; Fregni F
    ScientificWorldJournal; 2006 Apr; 6():472-90. PubMed ID: 16633700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No pain, no gain: balancing central versus peripheral benefits of analgesics in the age of the opioid crisis.
    Patel HH; Roth DM
    Br J Pharmacol; 2018 Mar; 175(5):855-856. PubMed ID: 29243218
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploiting Injury-Induced Peripheral Opioid Receptor Changes in Novel Analgesic Development for Chronic Pain.
    Hartrick CT
    Front Pain Res (Lausanne); 2022; 3():883164. PubMed ID: 35557854
    [No Abstract]   [Full Text] [Related]  

  • 33. Abdominal and Pelvic Pain: Current Challenges and Future Opportunities.
    Yuan T; Greenwood-Van Meerveld B
    Front Pain Res (Lausanne); 2021; 2():634804. PubMed ID: 35295470
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV and Chronic Pain, Part 2: Addressing the Opioid Public Health Crisis.
    Pullen SD
    Rehabil Oncol; 2017 Oct; 35(4):197-198. PubMed ID: 29662723
    [No Abstract]   [Full Text] [Related]  

  • 35. New ways to treat the pain of the opioid crisis.
    EClinicalMedicine; 2020 Jan; 18():100267. PubMed ID: 31993581
    [No Abstract]   [Full Text] [Related]  

  • 36. Addressing the opioid crisis in the Philippines: recognizing the severity and calling for proactive action.
    Cordero DA
    Korean J Pain; 2024 Apr; 37(2):182-184. PubMed ID: 38504388
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA outlines action on opioid crisis.
    Drug Ther Bull; 2018 Aug; 56(8):89. PubMed ID: 30135062
    [No Abstract]   [Full Text] [Related]  

  • 38. Visceral Pain: Basic Research Concepts and Therapeutic Interventions.
    Chaban VV
    Int J Res Nurs; 2015; 6(2):27-28. PubMed ID: 26962411
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcitonin receptor signal: a potential target for opioid use disorder?
    Marino RAM; Venniro M
    Neuropsychopharmacology; 2023 Dec; 48(13):1835-1836. PubMed ID: 37580458
    [No Abstract]   [Full Text] [Related]  

  • 40. Opioid: toward an effective strategy for better use.
    Kim YD
    Korean J Pain; 2019 Apr; 32(2):67-68. PubMed ID: 31091504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.